X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
female (11) 11
adult (9) 9
index medicus (9) 9
male (8) 8
middle aged (8) 8
cancer (6) 6
care and treatment (6) 6
endocrinology & metabolism (6) 6
patient outcomes (5) 5
aged (4) 4
aged, 80 and over (4) 4
carcinoma (4) 4
diagnosis (4) 4
risk factors (4) 4
surgery (4) 4
thyroid cancer (4) 4
usage (4) 4
follow-up studies (3) 3
health aspects (3) 3
iodine radioisotopes - therapeutic use (3) 3
neck (3) 3
thyroid (3) 3
thyroidectomy (3) 3
treatment outcome (3) 3
adenocarcinoma, follicular - drug therapy (2) 2
case studies (2) 2
contamination (2) 2
development and progression (2) 2
diagnosis, differential (2) 2
hormone withdrawal (2) 2
iodine (2) 2
life sciences (2) 2
magnetic resonance imaging (2) 2
management (2) 2
medical imaging (2) 2
metastases (2) 2
nuclear medicine (2) 2
oncology (2) 2
patients (2) 2
quality of life (2) 2
radioiodine therapy (2) 2
radiology, nuclear medicine & medical imaging (2) 2
radiopharmaceuticals - pharmacokinetics (2) 2
research (2) 2
retrospective studies (2) 2
salivary glands (2) 2
stimulated thyroglobulin (2) 2
thyroid carcinoma (2) 2
thyroid diseases (2) 2
thyroid gland (2) 2
thyroid neoplasms - drug therapy (2) 2
thyroid neoplasms - pathology (2) 2
thyroid neoplasms - surgery (2) 2
thyrotropin - adverse effects (2) 2
tomography (2) 2
tomography, emission-computed, single-photon (2) 2
ultrasonography (2) 2
[ sdv.mhep.psm ] life sciences [q-bio]/human health and pathology/psychiatrics and mental health (1) 1
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (1) 1
[ shs.eco ] humanities and social sciences/economies and finances (1) 1
[ shs.psy ] humanities and social sciences/psychology (1) 1
[sdv.mhep.psm]life sciences [q-bio]/human health and pathology/psychiatrics and mental health (1) 1
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (1) 1
[shs.eco]humanities and social sciences/economies and finances (1) 1
[shs.psy]humanities and social sciences/psychology (1) 1
ablation (1) 1
ablation techniques (1) 1
abridged index medicus (1) 1
acute myocardial-infarction (1) 1
adenocarcinoma, follicular - pathology (1) 1
adenocarcinoma, follicular - radiotherapy (1) 1
adenocarcinoma, follicular - surgery (1) 1
administration, oral (1) 1
adolescent (1) 1
age of onset (1) 1
agency (1) 1
alpha #6 (1) 1
alpha 6 (1) 1
aminopyridines - therapeutic use (1) 1
angiogenesis (1) 1
angiogenesis in-vitro (1) 1
animal tissues (1) 1
animals (1) 1
antineoplastic agents - therapeutic use (1) 1
benign thyroid-diseases (1) 1
bkm120 (1) 1
blocks (1) 1
blood circulation disorders (1) 1
bone sarcoma (1) 1
bone-marrow-cells (1) 1
brain (1) 1
brain - blood supply (1) 1
brain - diagnostic imaging (1) 1
brain - physiopathology (1) 1
brain diseases (1) 1
brain hemiatrophy (1) 1
brain perfusion spect (1) 1
brain tumors (1) 1
cachexia - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1663 - 1673
This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of... 
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Risk groups | Event-related potentials | Thyroid gland | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Cancer | Thyroid
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2018, Volume 59, Issue 1, pp. 121 - 126
Perturbation of thyroid iodide uptake is a well-documented side effect of the use of iodinated contrast media (ICM) administered intravenously. This side... 
Free iodide | Salivary glands | Iodide uptake | Iodinated contrast media | Thyroid | iodinated contrast media | URINARY IODINE | INDUCED APOPTOSIS | salivary glands | free iodide | iodide uptake | CANCER | NA+/I-SYMPORTER DISTRIBUTION | COMPUTED-TOMOGRAPHY | thyroid | RADIOIODINE THERAPY | IN-VIVO | MEDIA | TISSUES | DYSFUNCTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Thyroid, ISSN 1050-7256, 11/2016, Volume 26, Issue 11, pp. 1614 - 1622
Background: MicroSPECT/CT imaging was used to quantitatively evaluate how iodide uptake in the mouse thyroid is influenced by (i) route of iodine... 
Thyroid Radiology and Nuclear Medicine | Differentiated thyroid carcinoma | Hormone replacement therapy | Recombinant human TSH | MicroSPECT/CT | Iodine administration route | Radioiodine therapy | iodine administration route | differentiated thyroid carcinoma | microSPECT/CT | CANCER | radioiodine therapy | THERAPY | NA/I SYMPORTER | RHTSH | SODIUM-IODIDE SYMPORTER | ENDOCRINOLOGY & METABOLISM | recombinant human TSH | hormone replacement therapy | GENE-TRANSFER | SODIUM/IODIDE-SYMPORTER | CARCINOMA | EXPRESSION | VECTORS | Injections, Intravenous | Diet - adverse effects | Humans | Tomography, Emission-Computed, Single-Photon | Hormone Replacement Therapy - adverse effects | Recombinant Proteins - adverse effects | Thyrotropin - administration & dosage | Tissue Distribution | Radiopharmaceuticals - metabolism | Thyrotropin - adverse effects | Triiodothyronine - metabolism | Iodine - administration & dosage | Sodium Pertechnetate Tc 99m - pharmacokinetics | Thyrotropin - pharmacology | Injections, Subcutaneous | Sodium Pertechnetate Tc 99m - metabolism | Female | Triiodothyronine - pharmacokinetics | Thyroid Gland - drug effects | Triiodothyronine - administration & dosage | Radiopharmaceuticals - pharmacokinetics | Administration, Oral | Mice, Inbred C57BL | Injections, Intraperitoneal | Recombinant Proteins - pharmacology | Iodine Radioisotopes - pharmacokinetics | Recombinant Proteins - administration & dosage | Thyroid Gland - diagnostic imaging | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Animals | Iodine - adverse effects | Iodine Radioisotopes - metabolism | Thyroid Gland - metabolism
Journal Article
Thyroid, ISSN 1050-7256, 09/2018, Volume 28, Issue 9, pp. 1174 - 1179
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 09/2016, Volume 103, Issue 9, pp. 735 - 742
Background FDG PET (PET) ± computed tomography (CT) has increasingly been used in some areas of oncology imaging. It is sometimes performed outside... 
Soft tissue sarcoma | Adult | Bone sarcoma | PET-CT | PET
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 8/2011, Volume 268, Issue 8, pp. 1205 - 1212
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.